Search research articles
Contact Us
Filters
Showing results (1061-1070 of 1,076) with videos related to
Page
of 108
Sort By:
Nature Communications
|
January 9, 2024
Dual-plasmonic Au@Cu<sub>7</sub>S<sub>4</sub> yolk@shell nanocrystals for photocatalytic hydrogen production across visible to near infrared spectral region
Chun-Wen Tsao, Sudhakar Narra, Jui-Cheng Kao, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase
Victor J Cee, Alan C Cheng, Karina Romero, et al.
Journal of Medicinal Chemistry
|
December 4, 2013
Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors
Zihao Hua, Howard Bregman, John L Buchanan, et al.
Journal of Medicinal Chemistry
|
August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors
Michele H Potashman, James Bready, Angela Coxon, et al.
Respiratory Research
|
December 3, 2022
The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study
Yong-Hua Gao, Hai-Wen Lu, Bei Mao, et al.
Journal of Medicinal Chemistry
|
January 27, 2007
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase
Victor J Cee, Brian K Albrecht, Stephanie Geuns-Meyer, et al.
Liver Cancer
|
June 3, 2026
Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study
Jing-Kun Chen, Jia-Liang Wei, Zhen-Dong Yang, et al.
Journal of Medicinal Chemistry
|
January 27, 2007
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor
Brian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Journal of Medicinal Chemistry
|
February 19, 2008
Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity
Matthew W Martin, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor
Victor J Cee, Laurie B Schenkel, Brian L Hodous, et al.
Page
of 108
Search research articles
Search
Showing results (1061-1070 of 1,076) with videos related to
Sort By:
Page
of 108
Nature Communications
|
January 9, 2024
Dual-plasmonic Au@Cu<sub>7</sub>S<sub>4</sub> yolk@shell nanocrystals for photocatalytic hydrogen production across visible to near infrared spectral region
Chun-Wen Tsao, Sudhakar Narra, Jui-Cheng Kao, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 9, 2008
Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase
Victor J Cee, Alan C Cheng, Karina Romero, et al.
Journal of Medicinal Chemistry
|
December 4, 2013
Development of novel dual binders as potent, selective, and orally bioavailable tankyrase inhibitors
Zihao Hua, Howard Bregman, John L Buchanan, et al.
Journal of Medicinal Chemistry
|
August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitors
Michele H Potashman, James Bready, Angela Coxon, et al.
Respiratory Research
|
December 3, 2022
The Establishment of China Bronchiectasis Registry and Research Collaboration (BE-China): Protocol of a prospective multicenter observational study
Yong-Hua Gao, Hai-Wen Lu, Bei Mao, et al.
Journal of Medicinal Chemistry
|
January 27, 2007
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase
Victor J Cee, Brian K Albrecht, Stephanie Geuns-Meyer, et al.
Liver Cancer
|
June 3, 2026
Immune Checkpoint Inhibitor Rechallenge in Unresectable Hepatocellular Carcinoma: A Multicenter Efficacy and Safety Study
Jing-Kun Chen, Jia-Liang Wei, Zhen-Dong Yang, et al.
Journal of Medicinal Chemistry
|
January 27, 2007
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor
Brian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Journal of Medicinal Chemistry
|
February 19, 2008
Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity
Matthew W Martin, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry
|
August 6, 2010
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor
Victor J Cee, Laurie B Schenkel, Brian L Hodous, et al.
Page
of 108